ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Sees Large Drop in Short Interest

Posted by Stacy Sanders on Jul 25th, 2026

ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB – Get Free Report) was the recipient of a significant decline in short interest during the month of July. As of July 15th, there was short interest totaling 2,604 shares, a decline of 79.4% from the June 30th total of 12,632 shares. Approximately 0.3% of the shares of the company are short sold. Based on an average daily trading volume, of 14,991 shares, the days-to-cover ratio is presently 0.2 days.

ProShares Ultra Nasdaq Biotechnology Stock Performance

Shares of BIB opened at $97.99 on Friday. The stock has a 50-day moving average of $90.90 and a two-hundred day moving average of $85.92. The stock has a market cap of $82.31 million, a P/E ratio of 20.68 and a beta of 1.19. ProShares Ultra Nasdaq Biotechnology has a one year low of $49.24 and a one year high of $110.25.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the company. Kaizen Financial Strategies boosted its position in ProShares Ultra Nasdaq Biotechnology by 4.7% in the first quarter. Kaizen Financial Strategies now owns 5,565 shares of the exchange traded fund’s stock valued at $483,000 after buying an additional 250 shares during the last quarter. Citadel Advisors LLC purchased a new position in ProShares Ultra Nasdaq Biotechnology during the 3rd quarter worth approximately $307,000. Finally, Franklin Resources Inc. acquired a new stake in ProShares Ultra Nasdaq Biotechnology during the 2nd quarter valued at approximately $32,000.

ProShares Ultra Nasdaq Biotechnology Company Profile

(Get Free Report)

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day.